Profile of:

Rafael Ariza Ariza


Full name: Rafael Ariza Ariza

Current country: Spain

Membership level: Full

Type of membership: Member

Number of publications: 9

Disease control in patients with ankylosing spondylitis in real clinical practice in Spain: Results of the MIDAS study (2023)
https://pubmed.ncbi.nlm.nih.gov/36739123/

Disease control in patients with psoriatic arthritis in real clinical practice in Spain: MiDAS study (2023)
https://pubmed.ncbi.nlm.nih.gov/37061282/

Assessment of SpondyloArthritis International Society (ASAS) Consensus on Spanish Nomenclature for Spondyloarthritis. (2020)
https://pubmed.ncbi.nlm.nih.gov/?term=Ariza-Ariza

Recommendations for the use of Methotrexate in Psoriatic Arthritis (2018)
https://pubmed.ncbi.nlm.nih.gov/?term=Ariza-Ariza

Association between serum dickkopf-1 levels and disease duration in axial spondyloarthritis. (2017)
https://pubmed.ncbi.nlm.nih.gov/?term=Ariza-Ariza

Standards of care for patients with spondyloarthritis. (2014)
https://pubmed.ncbi.nlm.nih.gov/?term=Ariza%20R

A comparison of telephone and paper self-completed questionnaires of main patient-related outcome measures in patients with ankylosing spondylitis and psoriatic arthritis. (2013)
https://pubmed.ncbi.nlm.nih.gov/?term=Ariza-Ariza

Scoring with the Berlin MRI method for assessment of spinal inflammatory activity in patients with ankylosing spondylitis: a calibration exercise among rheumatologists. (2013)
https://pubmed.ncbi.nlm.nih.gov/?term=Ariza%20R&page=2

Low doses of etanercept can be effective in ankylosing spondylitis patients who achieve remission of the disease. (2011)
https://pubmed.ncbi.nlm.nih.gov/?term=Ariza-Ariza%20R&page=2